In This Section

Home / Learn / Webinars and eLearning
ACCC eLearning

Webinars and eLearning

The Association of Community Cancer Centers (ACCC) eLearning platform provides multidisciplinary education and resources that support the delivery of quality cancer care. With a variety of flexible online learning options that fit individual learning preferences, you can take your professional development to the next level through in-depth courses or gain quick knowledge in shorter learning formats.

Our live events and on-demand recordings are accessible on any device and at any time so you can watch and engage in ways that best suit your needs. Health professionals can claim CME/CPE/CNE credit for all applicable activities. The majority of the educational offerings are available at no cost.

Getting started is easy. On the ACCC eLearning home page, click the orange Log In button. You'll be redirected to a page where you can log in to your ACCC account. If you do not have an account, you can create a new profile by clicking on "Reset Password." Contact us if you need support.
Get Started

Explore by Topic

ACCCeLearning offers live and on-demand webinars, webcasts, and continuing education courses under the following topics:


Upcoming Webinars and Events


On-Demand Webinars

  • In this final webinar, hear from our experts Jordan Karwedsky, Financial Counselor, Green Bay Oncology, Wendi Waugh, BS, RT(R)(T), CMD, CRT, Administrative Director of SOMC Cancer Services & Ambulatory Infusion, Southern Ohio Medical Center, and Dr. Michael R. Gieske, Director of Lung Cancer Screening. Join us as we discuss prior authorization challenges in biomarker testing, importance of providing access to biomarker testing for underserved populations, how biomarkers are shaping the future of medicine, as well as what can be done at the policy level to allow for more access.

  • The unwinding of Medicaid has begun and affects one of the most vulnerable U.S. regions’ access to cancer-related services—from screening to treatment. In this webinar, the Appalachian Community Cancer Alliance provides an opportunity to gain insight on the scale of impact and how to help ensure continued access to cancer screening and treatment services for this patient population.

  • In the fourth webinar, we will hear from Gretchen Van Dyck, Financial Counselor from St. Vincent Hospital Regional Cancer Center and Rachelle Gill, Program/Department Coordinator II for Proton Therapy Appeals at Fred Hutchinson Cancer Center. Join us as we discuss radiation authorization submissions before treatment and strategies on how to work radiation authorization denials and appeals after treatment.

  • In the third webinar, we will hear from Jennifer Paquet, RN, BSN, Financial Assistance Patient Care Coordinator Supervisor from Bassett Cancer Institute and Aimee Hoch, MSW, LSW, Oncology Financial Navigator from Grand View Health Cancer Center. We will discuss barriers to radiology prior authorizations and provide insights on how to address them.

  • In the second webinar, we will hear from Andre D. Harvin, PharmD, MS, Executive Director of Pharmacy for Oncology at Cone Health. We will discuss how your pharmacy team can be a major ally and support in obtaining prior authorizations, help navigate biosimilar changes, and address medical necessity.

  • In the first webinar, we will hear from Sarah Hudson-DiSalle, PharmD, Rph, Pharmacy Manager, from The James Cancer Hospital, and Jordan Karwedsky, Financial Counselor from Green Bay Oncology. In this webinar, we discuss ACCC Prior Authorization Focus Group findings, payer recommendations, and how to best prepare for the prior authorization "blizzard" for next year.

  • This webinar will highlight how community cancer programs are using a new approach to optimize biomarker testing processes through the addition of a precision medicine steward. Precision medicine experts will outline strategies and key metrics that demonstrate how precision medicine stewardship can improve coordination and streamline workflows to ensure timely, equitable testing for patients who may benefit from targeted therapy.